Ina Research Inc. | Cash Flow

Fiscal year is April-March. All values JPY Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
49,440.00
32,101.00
1,180,869.00
28,036.00
172,748.00
Depreciation, Depletion & Amortization
214,823.00
207,164.00
181,776.00
122,592.00
102,467.00
Other Funds
53,060.00
32,650.00
863,013.00
9,066.00
26,882.00
Funds from Operations
211,203.00
271,915.00
136,080.00
141,562.00
248,333.00
Changes in Working Capital
1,955.00
146,705.00
35,322.00
143,508.00
396,030.00
Net Operating Cash Flow
209,248.00
125,210.00
171,402.00
1,946.00
644,363.00
Capital Expenditures
49,669.00
42,485.00
47,218.00
25,402.00
17,007.00
Sale of Fixed Assets & Businesses
1,486.00
-
-
31,843.00
39,044.00
Purchase/Sale of Investments
60,121.00
-
16,000.00
-
-
Net Investing Cash Flow
13,795.00
42,161.00
29,934.00
6,936.00
21,991.00
Cash Dividends Paid - Total
9,009.00
18,016.00
9,033.00
62.00
84.00
Issuance/Reduction of Debt, Net
79,425.00
11,515.00
123,183.00
87,679.00
13,437.00
Net Financing Cash Flow
88,434.00
6,501.00
132,216.00
87,615.00
13,351.00
Net Change in Cash
138,835.00
78,726.00
337,515.00
92,027.00
679,458.00
Free Cash Flow
159,579.00
82,725.00
218,620.00
25,510.00
627,356.00
Other Sources
1,857.00
324.00
1,284.00
496.00
-
Exchange Rate Effect
4,226.00
2,178.00
3,963.00
579.00
247.00
Other Uses
-
-
-
-
45.00
Miscellaneous Funds
-
-
-
1.00
-

About Ina Research

View Profile
Address
2148-188 Nishiminowa
Ina 399
Japan
Employees -
Website http://www.ina-research.co.jp
Updated 09/14/2018
Ina Research, Inc. engages in the development of pharmaceutical products. The company operates through Entrusted Testing and Environment segment. The Entrusted Testing segment covers the safe testing of pharmaceuticals, medical equipment, pesticides, food, and other chemicals and also handles the commissioned clinical trials for drug development.